Evaluating the Efficacy of AI-Assisted Quantitative Coronary Angiography in Reducing Procedural Time for Primary PCI

Joon Ho Ahn1, Seongho Park1, Seung Hun Lee1

  • 1Division of Cardiology, Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Korea.

Insights

AI-assisted quantitative coronary angiography (QCA) significantly reduced procedure time for ST-elevation myocardial infarction (STEMI) primary percutaneous coronary intervention (PCI). This AI tool streamlines stent sizing and optimization, potentially improving reperfusion times without increasing contrast use.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Artificial Intelligence in Medicine

Background:

  • Rapid reperfusion is critical for ST-elevation myocardial infarction (STEMI) outcomes.
  • Primary percutaneous coronary intervention (PCI) is a key reperfusion strategy.
  • Optimizing PCI procedure time is essential for patient care.

Purpose of the Study:

  • To evaluate the impact of AI-assisted quantitative coronary angiography (QCA) on primary PCI procedure time in STEMI patients.
  • To compare the efficiency and safety of AI-QCA-assisted PCI versus standard angiography-guided PCI.

Main Methods:

  • Single-center, retrospective study of 1,041 STEMI patients undergoing primary PCI.
  • Comparison between AI-QCA-assisted PCI (MPXA software) and angiography-guided PCI.
  • Propensity score matching (1:3 ratio) to minimize bias; primary endpoint: time from angiography to PCI completion.

Main Results:

  • AI-QCA-assisted PCI group showed a significant reduction in procedure time (34.9 vs. 39.5 minutes, P < 0.001) after matching.
  • No significant differences in contrast media volume, in-hospital mortality, or cardiac mortality were observed between groups.
  • AI-QCA primarily streamlined stent sizing and optimization processes.

Conclusions:

  • AI-assisted QCA significantly shortens primary PCI procedure time for STEMI.
  • Time savings may facilitate faster reperfusion, potentially improving clinical outcomes.
  • Larger studies are warranted to confirm the clinical benefits of AI-QCA in STEMI treatment.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522